Wells Fargo & Company Ani Pharmaceuticals Inc Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Wells Fargo & Company holds 7,493 shares of ANIP stock, worth $405,820. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,493
Previous 12,003 37.57%
Holding current value
$405,820
Previous $764,000 41.49%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$54.33 - $65.72 $245,028 - $296,397
-4,510 Reduced 37.57%
7,493 $447,000
Q2 2024

Aug 13, 2024
BUY
$58.53 - $68.82 $398,179 - $468,182
6,803 Added 130.83%
12,003 $764,000
Q1 2024

May 10, 2024
BUY
$54.2 - $69.69 $30,568 - $39,305
564 Added 12.17%
5,200 $359,000
Q4 2023

Feb 09, 2024
BUY
$48.72 - $65.43 $45,017 - $60,457
924 Added 24.89%
4,636 $255,000
Q3 2023

Nov 13, 2023
SELL
$50.28 - $64.61 $151,091 - $194,153
-3,005 Reduced 44.74%
3,712 $215,000
Q2 2023

Aug 15, 2023
BUY
$37.29 - $53.83 $115,002 - $166,011
3,084 Added 84.89%
6,717 $361,000
Q1 2023

May 12, 2023
BUY
$37.61 - $45.72 $102,035 - $124,038
2,713 Added 294.89%
3,633 $144,000
Q4 2022

Feb 13, 2023
SELL
$31.9 - $41.95 $12,122 - $15,941
-380 Reduced 29.23%
920 $37,000
Q3 2022

Nov 14, 2022
SELL
$29.83 - $38.01 $38,182 - $48,652
-1,280 Reduced 49.61%
1,300 $41,000
Q2 2022

Aug 12, 2022
SELL
$23.09 - $33.46 $131,497 - $190,554
-5,695 Reduced 68.82%
2,580 $76,000
Q1 2022

May 16, 2022
SELL
$26.91 - $47.15 $306,585 - $537,179
-11,393 Reduced 57.93%
8,275 $233,000
Q4 2021

Feb 14, 2022
BUY
$32.97 - $56.85 $74,644 - $128,708
2,264 Added 13.01%
19,668 $907,000
Q3 2021

Nov 15, 2021
SELL
$26.48 - $35.99 $102,345 - $139,101
-3,865 Reduced 18.17%
17,404 $571,000
Q2 2021

Aug 16, 2021
SELL
$31.86 - $38.6 $162,231 - $196,551
-5,092 Reduced 19.32%
21,269 $745,000
Q1 2021

May 13, 2021
SELL
$28.4 - $36.14 $264,205 - $336,210
-9,303 Reduced 26.09%
26,361 $952,000
Q4 2020

Feb 09, 2021
SELL
$23.69 - $31.47 $375,154 - $498,358
-15,836 Reduced 30.75%
35,664 $1.04 Million
Q3 2020

Nov 05, 2020
SELL
$26.38 - $33.1 $49,779 - $62,459
-1,887 Reduced 3.53%
51,500 $1.45 Million
Q2 2020

Aug 13, 2020
BUY
$29.93 - $50.1 $533,232 - $892,581
17,816 Added 50.09%
53,387 $1.73 Million
Q1 2020

May 14, 2020
BUY
$30.35 - $67.14 $1.08 Million - $2.39 Million
35,571 New
35,571 $1.45 Million

Others Institutions Holding ANIP

# of Institutions
211
Shares Held
18.7M
Call Options Held
11.7K
Put Options Held
10.5K
View Full List

About ANI PHARMACEUTICALS INC

ANIP Quotes by TradingView
  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $944M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email